← Open Payments lookup

JONSON LIN: Open Payments

NPI 1114101995 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$976 in 40 payments from 11 companies in 2025. Trend: 2023 $492 · 2024 $254 · 2025 $976

Food & beverage: $976
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$206
ABBVIE INC.6$139
Neurocrine BioSciences, Inc.6$129
E.R. Squibb & Sons, L.L.C.4$97
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$92
Alkermes, Inc.4$78
Bausch Health US, LLC3$67
Vanda Pharmaceuticals Inc.2$65
Lundbeck LLC3$61
Supernus Pharmaceuticals, Inc.1$24

Products named: UZEDY, VRAYLAR, INGREZZA, COBENFY, CAPLYTA, REXULTI, APLENZIN, FANAPT.

Industry payments across CA — which companies pay providers there.